Phase 3 study of new levodopa/carbidopa delivery system meets all efficacy endpointsApril 25, 2023Parkinson's DiseaseMovement Disorders
New assay hailed as a game changer for early Parkinson’s diagnosisApril 14, 2023Parkinson's DiseaseMovement Disorders
Mississippi–Ohio River valley linked to higher risk of Parkinson’s diseaseApril 11, 2023Parkinson's DiseaseMovement Disorders
Exercise tied to reduced Parkinson’s motor symptoms and increased well-beingMarch 30, 2023Parkinson's DiseaseMovement Disorders
What’s driving the "world’s fastest-growing brain disease"?March 17, 2023Parkinson's DiseaseMovement Disorders
Focused ultrasound ablation reduces dyskinesia in Parkinson’s diseaseMarch 8, 2023Parkinson's DiseaseMovement Disorders
Childhood nightmares a prelude to cognitive problems, Parkinson’s?March 7, 2023PediatricsSleep MedicineParkinson's DiseaseMovement DisordersAlzheimer's & Cognition
Childhood trauma tied to increased Parkinson’s disease severityMarch 2, 2023PediatricsParkinson's DiseaseMovement DisordersNeuromuscular Disorders
What’s new in brain health?February 16, 2023COVID-19 UpdatesAlzheimer's & CognitionMovement DisordersParkinson's DiseaseNeuromuscular DisordersTraumatic Brain InjuryPain
Can a ‘smart’ skin patch detect early neurodegenerative diseases?February 1, 2023Alzheimer's & CognitionParkinson's DiseaseMovement Disorders
Ecopipam reduces Tourette’s tics without common side effects in phase 2 trialJanuary 17, 2023PediatricsMovement DisordersNeurodevelopmental Disorders
Antiepileptic drugs tied to increased Parkinson’s disease riskJanuary 3, 2023Epilepsy & SeizuresParkinson's DiseaseMovement Disorders
Prodromal Parkinson’s disease tied to significant functional impairmentJanuary 3, 2023Parkinson's DiseaseMovement Disorders
Annual U.S. Parkinson’s disease incidence 50% higher than earlier estimatesDecember 21, 2022Parkinson's DiseaseMovement Disorders
